US 10676486
Macrocyclic RIP2 kinase inhibitors
granted A61PA61P29/00
Quick answer
US patent 10676486 (Macrocyclic RIP2 kinase inhibitors) held by Oncodesign SA expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oncodesign SA
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P29/00